Source: DGNews | Posted 9 years ago
FDA Grants Marketing Approval To Xalatan (Latanoprost) For Initial Treatment Of Elevated Eye Pressure
Tags:
First prescription eye drop in its class to receive a first-line indication for use in those with ocular hypertension and the most common form of glaucoma
PEAPACK, NJ -- December 23, 2002 -- Pharmacia Corporation (NYSE: PHA) announced today that the U.S. Food and Drug Administration (FDA) has approved the once-daily prescription eye drop Xalatan
Comments